Bristol Myers Expects Sales To Decline This Year; So Why Is The Stock Rising?
Bristol Myers Squibb Stock Rises Inside A Buy Zone On Street-Beating 2026 Outlook | Investor's Business DailyBREAKING: [Stocks Open Lower As Bitcoin Skids, Google Tumbles]---Bristol Myers Squibb (BMY) stock rose moderately on Thursday after the drugmaker reported adjusted earnings of 12.5 billion in fourth-quarter sales. On average, analysts polled by FactSet expected Bristol Myers to earn 12.28 billion in sales. During the year-ago period, the company earned ...